Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $19.12 in the prior trading day, Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed at $17.99, down -5.91%. In other words, the price has decreased by -$5.91 from its previous closing price. On the day, 7.67 million shares were traded.
Ratios:
Our goal is to gain a better understanding of APLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.25. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 2.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $44.
On December 17, 2024, Goldman Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $36.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.Morgan Stanley initiated its Equal-Weight rating on November 21, 2024, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Chopas James George sold 183 shares for $24.82 per share. The transaction valued at 4,543 led to the insider holds 47,955 shares of the business.
Chopas James George bought 183 shares of APLS for $4,543 on Mar 17 ’25. On Mar 05 ’25, another insider, Watson David O., who serves as the General Counsel of the company, sold 5,569 shares for $25.10 each. As a result, the insider received 139,789 and left with 138,730 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.89 while its Price-to-Book (P/B) ratio in mrq is 9.80.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $47.60, while it has fallen to a 52-week low of $16.98. The 50-Day Moving Average of the stock is -17.68%, while the 200-Day Moving Average is calculated to be -39.25%.
Shares Statistics:
A total of 124.50M shares are outstanding, with a floating share count of 104.61M. Insiders hold about 16.77% of the company’s shares, while institutions hold 98.91% stake in the company.
